NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
4 - Prentiss Christopher B
Filed:
2026-04-24
AccNo:
0001193125-26-178298
Size:
4 KB
发布时间04/25 01:30 UTC
首次发现04/25 01:32 UTC
热度106.3
重要度74
情绪0.00
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 464 字符
Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001193125-26-178298
Filing Date: 2026-04-24
Accepted: 2026-04-24 21:30:06
Documents: 1
Period of Report: 2026-04-22
MANNKIND CORP ( Issuer ) CIK : 0000899460 (see all company filings) EIN. : 133607736 | State of Incorp.: DE | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | 4 | ownership.html | 4
1 | 4 | ownership.xml | 4